Gender-related mortality trends among diabetic patients with ST-segment elevation myocardial infarction: Insights from a nationwide registry 1997–2010

European Heart Journal: Acute Cardiovascular Care

Volumn 2, Issue 4, 2013, Pages 342-349

  Roffi, Marco ^a   Radovanovic, Dragana ^b   Erne, Paul ^c   Urban, Philip ^d   Windecker, Stephan ^e   Eberli, Franz R ^f  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c LUZERNER KANTONSSPITAL   (Switzerland)

^d LA TOUR HOSPITAL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f Department of Visceral   (Sweden)

Author keywords

Diabetes mellitus; evidence based therapy; gender; primary percutaneous coronary intervention; reperfusion therapy; ST elevation myocardial infarction

Indexed keywords

DIABETES MELLITUS; EVIDENCE-BASED THERAPY; GENDER; PRIMARY PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION THERAPY; ST-ELEVATION MYOCARDIAL INFARCTION;

DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL RATE; SWITZERLAND;

EID: 84906904456     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872613490382     Document Type: Article

References (18)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378: 31–40.
2. Bhatt DL, Roe MT, Peterson ED, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004; 292: 2096–2104.
3. Roe MT, Parsons LS, Pollack CV, et al. Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction. Arch Intern Med 2005; 165: 1630–1636.
4. Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880–1890.
5. Roffi M, Chew DP, Mukherjee D, et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001; 104: 2767–2771.
6. Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765–775.
7. Norhammar A, Malmberg K, Ryden L, et al. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838–844.
8. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009; 119: 1728–1735.
9. Radovanovic D and Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart 2010; 96: 917–921.
10. Movahed MR, John J, Hashemzadeh M, et al. Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988–2004) based on race, gender, infarct location and comorbidities. Am J Cardiol 2009; 104: 1030–1034.
11. Cubbon RM, Wheatcroft SB, Grant PJ, et al. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J 2007; 28: 540–545.
12. Crowley A, Menon V, Lessard D, et al. Sex differences in survival after acute myocardial infarction in patients with diabetes mellitus (Worcester Heart Attack Study). Am Heart J 2003; 146: 824–831.
13. Meisinger C, Heier M, von Scheidt W, et al. Gender-Specific short and long-term mortality in diabetic versus nondiabetic patients with incident acute myocardial infarction in the reperfusion era (the MONICA/KORA Myocardial Infarction Registry). Am J Cardiol 2010; 106: 1680–1684.
14. Venskutonyte L, Malmberg K, Norhammar A, et al. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes. J Intern Med 2010; 268: 75–82.
15. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 2009; 119: 1873–1782.
16. Wiviott SD, Braunwald E, Angiolillo DJ, et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel – Thrombolysis in Myocardial Infarction 38. Circulation 2008; 118: 1626–1636.
17. Brogan GX, Peterson ED, Mulgund J, et al. Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. Diabetes Care 2006; 29: 9–14.
18. Anselmino M, Malmberg K, Ohrvik J, et al. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur J Cardiovasc Prev Rehabil 2008; 15: 216–223.